BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 10438593)

  • 1. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
    Isel C; Karn J
    J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
    Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
    Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.
    Kim YK; Bourgeois CF; Isel C; Churcher MJ; Karn J
    Mol Cell Biol; 2002 Jul; 22(13):4622-37. PubMed ID: 12052871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
    Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
    Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.
    Nekhai S; Zhou M; Fernandez A; Lane WS; Lamb NJ; Brady J; Kumar A
    Biochem J; 2002 Jun; 364(Pt 3):649-57. PubMed ID: 12049628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.
    Zhou M; Nekhai S; Bharucha DC; Kumar A; Ge H; Price DH; Egly JM; Brady JN
    J Biol Chem; 2001 Nov; 276(48):44633-40. PubMed ID: 11572868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.
    Chen D; Zhou Q
    Mol Cell Biol; 1999 Apr; 19(4):2863-71. PubMed ID: 10082552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.
    Bourgeois CF; Kim YK; Churcher MJ; West MJ; Karn J
    Mol Cell Biol; 2002 Feb; 22(4):1079-93. PubMed ID: 11809800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tackling Tat.
    Karn J
    J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
    Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
    J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription.
    García-Martínez LF; Mavankal G; Neveu JM; Lane WS; Ivanov D; Gaynor RB
    EMBO J; 1997 May; 16(10):2836-50. PubMed ID: 9184228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity.
    Nekhai S; Shukla RR; Kumar A
    J Virol; 1997 Oct; 71(10):7436-41. PubMed ID: 9311822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.
    Fujinaga K; Cujec TP; Peng J; Garriga J; Price DH; Graña X; Peterlin BM
    J Virol; 1998 Sep; 72(9):7154-9. PubMed ID: 9696809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
    Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
    J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.
    Parada CA; Roeder RG
    Nature; 1996 Nov; 384(6607):375-8. PubMed ID: 8934526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.
    Cujec TP; Okamoto H; Fujinaga K; Meyer J; Chamberlin H; Morgan DO; Peterlin BM
    Genes Dev; 1997 Oct; 11(20):2645-57. PubMed ID: 9334327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
    O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
    J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
    Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
    J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
    Liou LY; Herrmann CH; Rice AP
    J Virol; 2002 Nov; 76(21):10579-87. PubMed ID: 12368300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.